Abstract 1693: Elraglusib (9-ING-41), a glycogen synthase kinase-3β inhibitor in combination with imipridones for treatment of solid cancer

Authors: Maryam Ghandali, leiqing Zhang, Benedito A. Carneiro, Wafik S. El-Deiry

Published: 2025-04-21

DOI: 10.1158/1538-7445.am2025-1693

Source: Full article